Celldex Therapeutics, Inc.

Q1 2026 13F Holders

Symbol
CLDX
CUSIP
15117B202
Type
Equity
Class
COM NEW
Num filings
240
Total reported value, excl. options
$2.32 B
Manager Report Date Value ($000) Shares Option Type